Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

Jonathan P Rogers, Edward Chesney, Dominic Oliver, Thomas A Pollak, Philip McGuire, Paolo Fusar-Poli, Michael S Zandi, Glyn Lewis, Anthony S David, Jonathan P Rogers, Edward Chesney, Dominic Oliver, Thomas A Pollak, Philip McGuire, Paolo Fusar-Poli, Michael S Zandi, Glyn Lewis, Anthony S David

Abstract

Background: Before the COVID-19 pandemic, coronaviruses caused two noteworthy outbreaks: severe acute respiratory syndrome (SARS), starting in 2002, and Middle East respiratory syndrome (MERS), starting in 2012. We aimed to assess the psychiatric and neuropsychiatric presentations of SARS, MERS, and COVID-19.

Methods: In this systematic review and meta-analysis, MEDLINE, Embase, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature databases (from their inception until March 18, 2020), and medRxiv, bioRxiv, and PsyArXiv (between Jan 1, 2020, and April 10, 2020) were searched by two independent researchers for all English-language studies or preprints reporting data on the psychiatric and neuropsychiatric presentations of individuals with suspected or laboratory-confirmed coronavirus infection (SARS coronavirus, MERS coronavirus, or SARS coronavirus 2). We excluded studies limited to neurological complications without specified neuropsychiatric presentations and those investigating the indirect effects of coronavirus infections on the mental health of people who are not infected, such as those mediated through physical distancing measures such as self-isolation or quarantine. Outcomes were psychiatric signs or symptoms; symptom severity; diagnoses based on ICD-10, DSM-IV, or the Chinese Classification of Mental Disorders (third edition) or psychometric scales; quality of life; and employment. Both the systematic review and the meta-analysis stratified outcomes across illness stages (acute vs post-illness) for SARS and MERS. We used a random-effects model for the meta-analysis, and the meta-analytical effect size was prevalence for relevant outcomes, I2 statistics, and assessment of study quality.

Findings: 1963 studies and 87 preprints were identified by the systematic search, of which 65 peer-reviewed studies and seven preprints met inclusion criteria. The number of coronavirus cases of the included studies was 3559, ranging from 1 to 997, and the mean age of participants in studies ranged from 12·2 years (SD 4·1) to 68·0 years (single case report). Studies were from China, Hong Kong, South Korea, Canada, Saudi Arabia, France, Japan, Singapore, the UK, and the USA. Follow-up time for the post-illness studies varied between 60 days and 12 years. The systematic review revealed that during the acute illness, common symptoms among patients admitted to hospital for SARS or MERS included confusion (36 [27·9%; 95% CI 20·5-36·0] of 129 patients), depressed mood (42 [32·6%; 24·7-40·9] of 129), anxiety (46 [35·7%; 27·6-44·2] of 129), impaired memory (44 [34·1%; 26·2-42·5] of 129), and insomnia (54 [41·9%; 22·5-50·5] of 129). Steroid-induced mania and psychosis were reported in 13 (0·7%) of 1744 patients with SARS in the acute stage in one study. In the post-illness stage, depressed mood (35 [10·5%; 95% CI 7·5-14·1] of 332 patients), insomnia (34 [12·1%; 8·6-16·3] of 280), anxiety (21 [12·3%; 7·7-17·7] of 171), irritability (28 [12·8%; 8·7-17·6] of 218), memory impairment (44 [18·9%; 14·1-24·2] of 233), fatigue (61 [19·3%; 15·1-23·9] of 316), and in one study traumatic memories (55 [30·4%; 23·9-37·3] of 181) and sleep disorder (14 [100·0%; 88·0-100·0] of 14) were frequently reported. The meta-analysis indicated that in the post-illness stage the point prevalence of post-traumatic stress disorder was 32·2% (95% CI 23·7-42·0; 121 of 402 cases from four studies), that of depression was 14·9% (12·1-18·2; 77 of 517 cases from five studies), and that of anxiety disorders was 14·8% (11·1-19·4; 42 of 284 cases from three studies). 446 (76·9%; 95% CI 68·1-84·6) of 580 patients from six studies had returned to work at a mean follow-up time of 35·3 months (SD 40·1). When data for patients with COVID-19 were examined (including preprint data), there was evidence for delirium (confusion in 26 [65%] of 40 intensive care unit patients and agitation in 40 [69%] of 58 intensive care unit patients in one study, and altered consciousness in 17 [21%] of 82 patients who subsequently died in another study). At discharge, 15 (33%) of 45 patients with COVID-19 who were assessed had a dysexecutive syndrome in one study. At the time of writing, there were two reports of hypoxic encephalopathy and one report of encephalitis. 68 (94%) of the 72 studies were of either low or medium quality.

Interpretation: If infection with SARS-CoV-2 follows a similar course to that with SARS-CoV or MERS-CoV, most patients should recover without experiencing mental illness. SARS-CoV-2 might cause delirium in a significant proportion of patients in the acute stage. Clinicians should be aware of the possibility of depression, anxiety, fatigue, post-traumatic stress disorder, and rarer neuropsychiatric syndromes in the longer term.

Funding: Wellcome Trust, UK National Institute for Health Research (NIHR), UK Medical Research Council, NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London.

Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Study selection CINAHL=Cumulative Index to Nursing and Allied Health Literature.
Figure 2
Figure 2
Forest plots of pooled prevalence of anxiety (A), depression (B), and post-traumatic stress disorder (C) in individuals who recovered from coronavirus infection MERS-CoV=Middle East respiratory syndrome coronavirus. SARS-CoV=severe acute respiratory syndrome coronavirus.

References

    1. Arciniegas DB, Anderson CA. Viral encephalitis: neuropsychiatric and neurobehavioral aspects. Curr Psychiatry Rep. 2004;6:372–379.
    1. Dubé B, Benton T, Cruess DG, Evans DL. Neuropsychiatric manifestations of HIV infection and AIDS. J Psychiatry Neurosci. 2005;30:237–246.
    1. Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol. 2001;54(suppl 1):S44–S52.
    1. Rabiee A, Nikayin S, Hashem MD. Depressive symptoms after critical illness: a systematic review and meta-analysis. Crit Care Med. 2016;44:1744–1753.
    1. Nikayin S, Rabiee A, Hashem MD. Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2016;43:23–29.
    1. Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 2015;43:1121–1129.
    1. Lu R, Zhao X, Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574.
    1. Desforges M, Le Coupanec A, Dubeau P. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12:14.
    1. Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386.
    1. WHO 2019 novel coronavirus (2019nCoV): strategic preparedness and response plan. Feb 3, 2020.
    1. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.03.026. published online March 28.
    1. WHO . World Health Organization; Geneva: 2018. The ICD-11 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines.
    1. WHO Mental health and psychosocial considerations during the COVID-19 outbreak. March 18, 2020.
    1. The Lancet Psychiatry Send in the therapists? Lancet Psychiatry. 2020;7:291.
    1. Lewnard JA, Lo NC. Scientific and ethical basis for social-distancing interventions against COVID-19. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30190-0. published online March 23.
    1. Brooks SK, Webster RK, Smith LE. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–920.
    1. Asmundson GJG, Taylor S. Coronaphobia: fear and the 2019-nCoV outbreak. J Anxiety Disord. 2020;70
    1. Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. BMJ. 2020;368
    1. Chaves C, Castellanos T, Abrams M, Vazquez C. The impact of economic recessions on depression and individual and social well-being: the case of Spain (2006–2013) Soc Psychiatry Psychiatr Epidemiol. 2018;53:977–986.
    1. Xiang Y-T, Yang Y, Li W. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7:228–229.
    1. Siu JY. The SARS-associated stigma of SARS victims in the post-SARS era of Hong Kong. Qual Health Res. 2008;18:729–738.
    1. Jones C, Humphris GM, Griffiths RD. Psychological morbidity following critical illness—the rationale for care after intensive care. Clin Intensive Care. 1998;9:199–205.
    1. Mao L, Jin H, Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.1127. published online April 10.
    1. Li Y, Bai W, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020 doi: 10.1002/jmv.25728. published online Feb 27.
    1. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444–1448.
    1. Chu H, Chan JF-W, Yuen TT-T. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020 doi: 10.1016/S2666-5247(20)30004-5. published online April 21.
    1. Pleasure SJ, Green AJ, Josephson SA. The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.1065. published online April 10.
    1. Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020 doi: 10.1016/J.BBI.2020.04.027. published online April 13.
    1. Kępińska AP, Iyegbe CO, Vernon AC, Yolken R, Murray RM, Pollak TA. Schizophrenia and influenza at the centenary of the 1918–1919 Spanish influenza pandemic: mechanisms of psychosis risk. Front Psychiatry. 2020;11:72.
    1. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974–978.
    1. Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid-Based Healthc. 2018;16:195–203.
    1. Wells G, Shea B, O'Connell D, Peterson J. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
    1. Lee DTS, Wing YK, Leung HCM. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin Infect Dis. 2004;39:1247–1249.
    1. Almutairi AF, Adlan AA, Balkhy HH, Abbas OA, Clark AM. “It feels like I'm the dirtiest person in the world.”: exploring the experiences of healthcare providers who survived MERS-CoV in Saudi Arabia. J Infect Public Health. 2018;11:187–191.
    1. Koller DF, Nicholas DB, Goldie RS, Gearing R, Selkirk EK. When family-centered care is challenged by infectious disease: pediatric health care delivery during the SARS outbreaks. Qual Health Res. 2006;16:47–60.
    1. Maunder R, Hunter J, Vincent L. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. CMAJ. 2003;168:1245–1251.
    1. Mok E, Chung BP, Chung JW, Wong TK. An exploratory study of nurses suffering from severe acute respiratory syndrome (SARS) Int J Nurs Pract. 2005;11:150–160.
    1. Tiwari A, Chan S, Wong A. Severe acute respiratory syndrome (SARS) in Hong Kong: patients' experiences. Nurs Outlook. 2003;51:212–219.
    1. Li AM, Chan CHY, Chan DFY. Long-term sequelae of SARS in children. Paediatr Respir Rev. 2004;5:296–299.
    1. Mak WWS, Law RW, Woo J, Cheung FM, Lee D. Social support and psychological adjustment to SARS: the mediating role of self-care self-efficacy. Psychol Health. 2009;24:161–174.
    1. Mak IWC, Chu CM, Pan PC, Yiu MGC, Ho SC, Chan VL. Risk factors for chronic post-traumatic stress disorder (PTSD) in SARS survivors. Gen Hosp Psychiatry. 2010;32:590–598.
    1. Bonanno GA, Ho SMY, Chan JCK. Psychological resilience and dysfunction among hospitalized survivors of the SARS epidemic in Hong Kong: a latent class approach. Health Psychol. 2008;27:659–667.
    1. Sheng B, Cheng SKW, Lau KK, Li HL, Chan ELY. The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. Eur Psychiatry. 2005;20:236–242.
    1. Cheng SK, Wong CW, Tsang J, Wong KC. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS) Psychol Med. 2004;34:1187–1195.
    1. Cheng SKW, Chong GHC, Chang SSY. Adjustment to severe acute respiratory syndrome (SARS): roles of appraisal and post-traumatic growth. Psychol Health. 2006;21:301–317.
    1. Wing YK, Leung CM. Mental health impact of severe acute respiratory syndrome: a prospective study. Hong Kong Med J. 2012;18(suppl 3):24–27.
    1. Siu JY. Coping with future epidemics: Tai chi practice as an overcoming strategy used by survivors of severe acute respiratory syndrome (SARS) in post-SARS Hong Kong. Health Expect. 2016;19:762–772.
    1. Lee S, Chan LYY, Chau AMY, Kwok KPS, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Soc Sci Med. 2005;61:2038–2046.
    1. Lam MH-B, Wing Y-K, Yu MW-M. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169:2142–2147.
    1. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS) J Trauma Stress. 2005;18:39–42.
    1. Kwek S-K, Chew W-M, Ong K-C. Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge. J Psychosom Res. 2006;60:513–519.
    1. Wu KK, Chan SK, Ma TM. Posttraumatic stress after SARS. Emerg Infect Dis. 2005;11:1297–1300.
    1. Lee AM, Wong JG, McAlonan GM. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry. 2007;52:233–240.
    1. Lee SH, Shin H-S, Park HY. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry Investig. 2019;16:59–64.
    1. Lam SP, Tsui E, Chan KS, Lam CL, So HP. The validity and reliability of the functional impairment checklist (FIC) in the evaluation of functional consequences of severe acute respiratory distress syndrome (SARS) Qual Life Res. 2006;15:217–231.
    1. Hong X, Currier GW, Zhao X, Jiang Y, Zhou W, Wei J. Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year follow-up study. Gen Hosp Psychiatry. 2009;31:546–554.
    1. Batawi S, Tarazan N, Al-Raddadi R. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS) Health Qual Life Outcomes. 2019;17:101.
    1. Guo L, Han Y, Li J. Long-term outcomes in patients with severe acute respiratory syndrome treated with oseltamivir: a 12-year longitudinal study. Int J Clin Exp Med. 2019;12:12464–12471.
    1. Tansey CM, Louie M, Loeb M. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167:1312–1320.
    1. Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15:543–550.
    1. Helms J, Kremer S, Merdji H. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020 doi: 10.1056/NEJMc2008597. published online April 15.
    1. Chen G, Wu D, Guo W. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020 doi: 10.1172/JCI137244. published online April 13.
    1. Chen N, Zhou M, Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
    1. Moriguchi T, Harii N, Goto J. A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55–58.
    1. Leung CW, Kwan YW, Ko PW. Severe acute respiratory syndrome among children. Pediatrics. 2004;113:e535–e543.
    1. Lee JY, Kim Y-J, Chung EH. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis. 2017;17:498.
    1. Schneider E, Duncan D, Reiken M. SARS in pregnancy. AWHONN Lifelines. 2004;8:122–128.
    1. Guery B, Poissy J, el Mansouf L. Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013;381:2265–2272.
    1. Cheng SKW, Sheng B, Lau KK. Adjustment outcomes in Chinese patients following one-month recovery from severe acute respiratory syndrome in Hong Kong. J Nerv Ment Dis. 2004;192:868–871.
    1. Arabi YM, Harthi A, Hussein J. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) Infection. 2015;43:495–501.
    1. Avendano M, Derkach P, Swan S. Clinical course and management of SARS in health care workers in Toronto: a case series. CMAJ. 2003;168:1649–1660.
    1. Hong K-H, Choi J-P, Hong S-H. Predictors of mortality in Middle East respiratory syndrome (MERS) Thorax. 2018;73:286–289.
    1. Kim H-C, Yoo S-Y, Lee B-H, Lee SH, Shin H-S. Psychiatric findings in suspected and confirmed Middle East respiratory syndrome patients quarantined in hospital: a retrospective chart analysis. Psychiatry Investig. 2018;15:355–360.
    1. Alhumaid S, Tobaiqy M, Albagshi M. MERS-CoV transmitted from animal-to-human vs MERSCoV transmitted from human-to-human: comparison of virulence and therapeutic outcomes in a Saudi hospital. Trop J Pharm Res. 2018;17
    1. Noorwali AA, Turkistani AM, Asiri SI. Descriptive epidemiology and characteristics of confirmed cases of Middle East respiratory syndrome coronavirus infection in the Makkah Region of Saudi Arabia, March to June 2014. Ann Saudi Med. 2015;35:203–209.
    1. Saad M, Omrani AS, Baig K. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301–306.
    1. Mackay IF, Garrah JM, Tabah BM, Freeman L, Maher MM, Macdonald CL. Adverse drug reactions associated with the use of ribavirin in the treatment of severe acute respiratory syndrome (SARS) J Popul Ther Clin Pharmacol. 2005;12:e165–e179.
    1. Lau AC, So LK, Miu FP. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol. Respirology. 2004;9:173–183.
    1. Chua SE, Cheung V, McAlonan GM. Stress and psychological impact on SARS patients during the outbreak. Can J Psychiatry. 2004;49:385–390.
    1. Jeong H, Yim HW, Song Y-J. Mental health status of people isolated due to Middle East Respiratory Syndrome. Epidemiol Health. 2016;38
    1. Loutfy MR, Blatt LM, Siminovitch KA. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA. 2003;290:3222–3228.
    1. Hui DS, Wong KT, Ko FW. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128:2247–2261.
    1. Han Y, Geng H, Feng W. A follow-up study of 69 discharged SARS patients. J Tradit Chin Med. 2003;23:214–217.
    1. Yoon M-K, Kim S-Y, Ko H-S, Lee M-S. System effectiveness of detection, brief intervention and refer to treatment for the people with post-traumatic emotional distress by MERS: a case report of community-based proactive intervention in South Korea. Int J Ment Health Syst. 2016;10:51.
    1. Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37.
    1. Mak IWC, Chu CM, Pan PC, Yiu MGC, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009;31:318–326.
    1. Lau S-T, Yu W-C, Mok N-S, Tsui P-T, Tong W-L, Cheng SW. Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS) Int J Cardiol. 2005;100:167–169.
    1. Leow MK-S, Kwek DS-K, Ng AW-K, Ong K-C, Kaw GJ-L, Lee LS-U. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Clin Endocrinol. 2005;63:197–202.
    1. Hui DS, Joynt GM, Wong KT. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401–409.
    1. Lau HM-C, Lee EW-C, Wong CN-C, Ng GY-F, Jones AY-M, Hui DS-C. The impact of severe acute respiratory syndrome on the physical profile and quality of life. Arch Phys Med Rehabil. 2005;86:1134–1140.
    1. Li TS, Gomersall CD, Joynt GM, Chan DPS, Leung P, Hui DSC. Long-term outcome of acute respiratory distress syndrome caused by severe acute respiratory syndrome (SARS): an observational study. Crit Care Resusc. 2006;8:302–308.
    1. Tso EYK, Tsang OTY, Choi KW. Persistence of physical symptoms in and abnormal laboratory findings for survivors of severe acute respiratory syndrome. Clin Infect Dis. 2004;38
    1. Lo YL, Leong HN, Hsu LY. Autonomic dysfunction in recovered severe acute respiratory syndrome patients. Can J Neurol Sci. 2005;32:264.
    1. Cheng SK-W, Tsang JS-K, Ku K-H, Wong C-W, Ng Y-K. Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases. Br J Psychiatry. 2004;184:359–360.
    1. Lau HM-C, Ng GY-F, Jones AY-M, Lee EW-C, Siu EH-K, Hui DS-C. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother. 2005;51:213–219.
    1. Kong X, Zheng K, Tang M. Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19. medRxiv. 2020 doi: 10.1101/2020.03.24.20043075. published online April 5. (preprint)
    1. Yang L, Wu D, Hou Y. Analysis of psychological state and clinical psychological intervention model of patients with COVID-19. medRxiv. 2020 doi: 10.1101/2020.03.22.20040899. published online March 24. (preprint)
    1. Zhang B, Zhou X, Qiu Y. Clinical characteristics of 82 death cases with COVID-19. medRxiv. 2020 doi: 10.1101/2020.02.26.20028191. published online Feb 27. (preprint)
    1. Huang Y, Yang R, Xu Y, Gong P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv. 2020 doi: 10.1101/2020.02.27.20029009. published online March 5. (preprint)
    1. Qi D, Yan X, Tang X. Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: a retrospective, descriptive, multiple-center study. medRxiv. 2020 doi: 10.1101/2020.03.01.20029397. published online March 3: (preprint).
    1. Leung KS-S, Ng TT-L, Wu AK-L. A territory-wide study of early COVID-19 outbreak in Hong Kong community: a clinical, epidemiological and phylogenomic investigation. medRxiv. 2020 doi: 10.1101/2020.03.30.20045740. published online April 7. (preprint)
    1. Fu S, Fu X, Song Y. Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China. medRxiv. 2020 doi: 10.1101/2020.04.03.20051763. published online April 6. (preprint)
    1. Lam CLK, Gandek B, Ren XS, Chan MS. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol. 1998;51:1139–1147.
    1. Lam C, Lauder I, Lam T, Gandek B. Population based norming of the Chinese (HK) version of the SF36 health survey. Hong Kong Pract. 1999;21:460–470.
    1. Wilson N, Kvalsvig A, Barnard LT, Baker MG. Case-fatality risk estimates for COVID-19 calculated by using a lag time for fatality. Emerg Infect Dis. 2020 doi: 10.3201/eid2606.200320. published online March 13.
    1. Morfopoulou S, Brown JR, Davies EG. Human coronavirus OC43 associated with fatal encephalitis. N Engl J Med. 2016;375:497–498.
    1. Nilsson A, Edner N, Albert J, Ternhag A. Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child. Infect Dis. 2020;52:419–422.
    1. Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. 2004;113:e73–e76.
    1. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034.
    1. Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci. 2016;17:497–511.
    1. Hopkins RO, Weaver LK, Pope D, Orme JF, Jr, Bigler ED, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;160:50–56.
    1. Oeyen SG, Vandijck DM, Benoit DD, Annemans L, Decruyenaere JM. Quality of life after intensive care: a systematic review of the literature. Crit Care Med. 2010;38:2386–2400.
    1. Rockwood K. Delays in the discharge of elderly patients. J Clin Epidemiol. 1990;43:971–975.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera